What’s more worrisome, potential disease-carrying mosquitoes or releasing self-perpetuating CRISPR gene drive out into the wide world to combat them? We know how the mosquitoes would answer that question, right? And they are fighting back, in a sense, at least in the context of experiments. Mosquitoes were able to develop resistance to gene drive intended […]
Mosquitoes swat back via resistance to CRISPR gene drive Read More »
There’s always debate about stem cells and regenerative medicine, right? There are very strong opinions in our field. Here is a list of 10 current, provocative questions. I have my own ideas about the answers to these. Weigh in with comments with your answers. I’m going to do a follow up post with some discussion of the
10 provocative stem cell questions: what are your answers? Read More »
The Scientists March on Washington (aka March for Science @ScienceMarchDC) is one of the biggest science movements I’ve ever seen. It’s gone from zero to sixty in about 2 seconds now with hundreds of thousands of supporters, but some important questions are arising about this event and its organizers. I continue to be enthusiastic about the March, but this week I’ve
4 key questions for March for Science organizers & what info I gathered on them Read More »
In the whirlwind that is the stem cell and regenerative medicine world, there are many concerning things that need attention, but also good stuff happens too and this post focuses on the positive. The Asterias spinal cord injury clinical trial, a phase 1/2a trial called SCiStar, continues to make encouraging news with a clean safety profile
Good stem cell news on trials, FDA, cool new papers & more Read More »
It was just over a decade ago that I started making websites and it’s been a wild ride. My first site was at the domain name www.chromatin.com, which I was fortunate to have been able to get for a good deal way back when…I think in 2005. You can see here an early 2007 copy
~10th anniversary of my 1st website: reflecting on wild ride Read More »
The first ten days of Donald Trump’s presidency have been just as extreme as many had feared including those of us in the scientific community, but the early reactions of scientists to fight Trump’s agenda have been encouraging. We’ve collectively been sparked to “get out of the lab” and do something about it. There are many
Scientists battle Trump agenda on multiple fronts Read More »
The 21st Century Cures Act specifies some new FDA rules about investigational stem cell-based regenerative medicine therapies and perhaps most importantly defined a new class of product called a “Regenerative Advanced Therapy” or RAT, which is entitled to an expedited review. The FDA already has a new page up on RATs, which specifies the specifics of
FDA Regenerative Advanced Therapy Designation Rules Are Up in Response to Cures Act Read More »
The website Law360 has an interesting update on the proposed class action lawsuit against the San Diego stem cell clinic Stemgenex. Note that it seems you can read the full Law360 article without a subscription if you open the site in Chrome as your web browser. See more background on Stemgenex and on this case
Update on patients lawsuit against stem cell clinic, Stemgenex Read More »
I’m putting together a list of stem cell and regenerative medicine biotech companies for a blog post, including both public and private. I’ve got a good list already, but want it to be fairly comprehensive. I’m also curious what readers think are the most promising ones and why. So weigh in with comments please or
What is your favorite stem cell/regen med biotech & why? Read More »
